Remove Cardiovascular Disease Remove Patient Care Remove Ultrasound
article thumbnail

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

DAIC

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

article thumbnail

GE HealthCare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-quality Cardiac Images

DAIC

milla1cf Wed, 04/03/2024 - 18:58 April 3, 2024 — GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid cardiac assessments at the point of care on Vscan Air SL. The integration of Caption AI with the Vscan Air SL handheld ultrasound opens an entirely new chapter for cardiac screening.

article thumbnail

Philips launches Duo Venous Stent System for Treatment of Symptomatic Venous Outflow Obstruction

DAIC

Impacting 25 million people globally [1], deep venous disease results from venous thromboembolism, a condition that occurs when a blood clot forms in the vein [2]. It is the third most common cardiovascular disease [2]. Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction.

Stents 105
article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

24 and how those may impact clinical practice and patient care in this deep dive clinical trial session. Clinical and Investigative Horizons (Session 410) Sunday, April 7 4:30 – 5:45 p.m. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. One promising strategy is the formation of creative partnerships between patients and their healthcare teams. Key contributions: Advanced cardiac imaging (e.g.,

article thumbnail

Women and Black Patients Less Likely to Receive Catheter-based Treatment for Pulmonary Embolism According to REAL-PE Analysis Presented at SCAI 2024

DAIC

Ultrasound-assisted catheter-directed thrombolysis (USCDT), a common invasive treatment option for PE, enables deeper penetration of the clot-busting medication into the clot, restoring normal blood flow faster. PE affects around 900,000 people in the U.S. each year, with 10-30% dying within one month of diagnosis.

Embolism 122
article thumbnail

Emergency Department Syncope Workup: After H and P, ECG is the Only Test Required for Every Patient.

Dr. Smith's ECG Blog

Check : [vitals, SOB, Chest Pain, Ultrasound] If the patient has Abdominal Pain, Chest Pain, Dyspnea or Hypoxemia, Headache, Hypotension , then these should be considered the primary chief complaint (not syncope). Aortic Dissection, Valvular (especially Aortic Stenosis), Tamponade. Age greater than 65 (Sarasin and STePS) 3.